University of Missouri researchers develop a new vaccine for bovine anaplasmosis, a $1.6B annual cost to Missouri's cattle industry.

University of Missouri researchers have created a new vaccine to protect cattle against bovine anaplasmosis, a devastating tick-borne disease costing Missouri's cattle industry $1.6 billion annually. The live, genetically modified vaccine offers protective immunity and could help alleviate global economic losses from the disease, which impact cattle production, treatment costs and deaths.

August 28, 2024
37 Articles